1. Wheeler GP. Studies related to the mechanism of action of cytotoxic alkylating agents. Cancer Res 1962; 22:65 1-88.
2. Balali M, Hefazi M. The clinical toxicology of sulfur mustard. Arch Iran Med 2005; 8 :162-179.
3. Balali M, Balali B. Sulphur mustard poisoning and its complications in Iranian veterans. IJM 2009; 34:155-171.
4. Compton JF. Chemical and toxicological properties. In: Military Chemical and Biological Agents,? Caldwell; 1997. p. 5-17.
5. Abbas AY Taher. Cleft lip and palate in Tehran. Cleft Palate Craniofac J 1992; 29:1.
6. WHO. Health aspect of biological and chemical weapons. Geneva: WHO, 1970.
7. Lakshmana Rao PV, Vijayaraghavan R, Bhaskar ASB. Sulphur mustard induced DNA damage in mice after dermal and inhalation exposure. Toxicology 1999; 139:39-51.
8. Ludlum DB, Papirmeister B.
DNA modification by sulfur mustards and nitrosoureas and repair of these lesions. Basic Life Sci 1986; 38:119-125.
10. Freitag L, Firusian N, Stamatis G, Greschuchna D. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest 1991; 1436-1441.
11. Monica W, Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Pre Dis Med? 2009; 24:19-29.
12. Aasted A, Darre E, Wulf HC. Mustard gas: clinical toxicological and mutagenuc aspects based on modern experience. Ann Plast Surg 1987; 19:330-333.
13. Easton DF, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 1988; 45:652-659.
14. Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 1989; 27:419-435.
15. Ribiro PL, Mitra RS, Bernstein IA. Assessment of the role of DNA damage and repair in the survival of primary cultures of rat cutaneous keratinocytes exposed to bis (2-chloroethyl) sulfide. Toxicol Appl Pharmacol 1991; 111:342-351.
16. Wormser U, Izrael M, Van der Zee EA, Brodsky B, Yanai J A chick model for the mechanisms of mustard gas neurobehavioral teratogenicity, Neurotoxicolo.Teratolo 2005; 27:65-71.
17. Young DL, Schneider RA, Hu D, Helms JA. Genetic and teratogenic approaches to craniofacial development. Crit Rev Oral Biol Med 2000; 11:304-317.
18. Murray JC. Gene/environment causes of cleft lip/palate. Clin Genet 2002; 61:248-256.
19. Strauss RP. The organization and delivery of craniofacial health services: the state of the art. Cleft Palate Craniofac J 1999; 36:189-195.
20. Vanderas AP. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J 1987; 24:216-225.
21. OginoT. Congenital anomalies of the hand:asian perspective. Clin Orthop 1996; 323:12-21.
22. Ogino T, Kato H. Clinical and experimental studies on teratogenic mechanisms of congenital absence of digits in longitudinal deficiencies. Cong Anom 1993; 33:187-196.
23. Donovan J, Kordylewska A, Jan YN, Utset MF.
tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 2002; 12:1605-1610.
24. Korkmaz A, Tanand D, Russel J. Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies. Interdiscip Toxicol 2008; 1:22–26.
25. Papirmeister B, Gross CI, Meier HL, Petrali JP,Johnson JB. Molecular basis of mustard-induced vesication. Fundam Appl Toxicol 1985; 5:134-139.
26. Balali M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006; 99:273–284.
27. Pour-Jafari H. Fetal deaths and parental exposure to chemical warfare agents. Med J Islamic Rep Iran 1992; 6:87-88.
28. Hackett PL, Rommereim RL, Burton FG, Buschbom RL, Sasser LB. Teratology studies on lewisite and sulfur mustard agents: Effects of sulfur mustard in rats and rabbits: Final Report: Frederick, MD: U.S. Army Medical Research and Development Command, Department of the Army. AD-A 1987; 187- 495.
29. McNamara BP, Owens EJ, Christensen MK, Vocei FJ, Ford DF, Rozimarek N. Toxicological basis for controlling levels of mustard in the environment. EB-SP-74030. Edgewood Arsenal. Aberdeen Proving Grounds, MD. Proving Ground, MD. 1975.